SE174792C1 - - Google Patents
Info
- Publication number
- SE174792C1 SE174792C1 SE174792DA SE174792C1 SE 174792 C1 SE174792 C1 SE 174792C1 SE 174792D A SE174792D A SE 174792DA SE 174792 C1 SE174792 C1 SE 174792C1
- Authority
- SE
- Sweden
- Prior art keywords
- potassium
- deoxytetracycline
- tetracycline
- carried out
- concentration
- Prior art date
Links
- 239000004098 Tetracycline Substances 0.000 claims description 19
- 229960002180 tetracycline Drugs 0.000 claims description 19
- 229930101283 tetracycline Natural products 0.000 claims description 19
- 235000019364 tetracycline Nutrition 0.000 claims description 19
- 150000003522 tetracyclines Chemical class 0.000 claims description 19
- LPXPTNMVRIOKMN-UHFFFAOYSA-M sodium nitrite Chemical compound [Na+].[O-]N=O LPXPTNMVRIOKMN-UHFFFAOYSA-M 0.000 claims description 14
- 239000007800 oxidant agent Substances 0.000 claims description 13
- 239000011541 reaction mixture Substances 0.000 claims description 11
- 238000005805 hydroxylation reaction Methods 0.000 claims description 9
- 238000000034 method Methods 0.000 claims description 8
- 235000010288 sodium nitrite Nutrition 0.000 claims description 7
- KMUONIBRACKNSN-UHFFFAOYSA-N potassium dichromate Chemical compound [K+].[K+].[O-][Cr](=O)(=O)O[Cr]([O-])(=O)=O KMUONIBRACKNSN-UHFFFAOYSA-N 0.000 claims description 6
- NLKNQRATVPKPDG-UHFFFAOYSA-M potassium iodide Chemical compound [K+].[I-] NLKNQRATVPKPDG-UHFFFAOYSA-M 0.000 claims description 6
- 229940072172 tetracycline antibiotic Drugs 0.000 claims description 4
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 claims description 3
- AZFNGPAYDKGCRB-XCPIVNJJSA-M [(1s,2s)-2-amino-1,2-diphenylethyl]-(4-methylphenyl)sulfonylazanide;chlororuthenium(1+);1-methyl-4-propan-2-ylbenzene Chemical compound [Ru+]Cl.CC(C)C1=CC=C(C)C=C1.C1=CC(C)=CC=C1S(=O)(=O)[N-][C@@H](C=1C=CC=CC=1)[C@@H](N)C1=CC=CC=C1 AZFNGPAYDKGCRB-XCPIVNJJSA-M 0.000 claims description 3
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims description 3
- 229910052740 iodine Inorganic materials 0.000 claims description 3
- 239000011630 iodine Substances 0.000 claims description 3
- 238000007254 oxidation reaction Methods 0.000 claims description 3
- 239000004304 potassium nitrite Substances 0.000 claims description 3
- 235000010289 potassium nitrite Nutrition 0.000 claims description 3
- 239000012286 potassium permanganate Substances 0.000 claims description 3
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 claims description 2
- 230000003115 biocidal effect Effects 0.000 claims description 2
- 229910052700 potassium Inorganic materials 0.000 claims description 2
- 239000011591 potassium Substances 0.000 claims description 2
- -1 potassium ferricyanide Chemical compound 0.000 claims description 2
- 230000003647 oxidation Effects 0.000 claims 2
- 238000006243 chemical reaction Methods 0.000 description 16
- 239000000243 solution Substances 0.000 description 14
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 9
- 238000002474 experimental method Methods 0.000 description 7
- 238000012360 testing method Methods 0.000 description 7
- 229910052725 zinc Inorganic materials 0.000 description 7
- 239000011701 zinc Substances 0.000 description 7
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 6
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 6
- 230000033444 hydroxylation Effects 0.000 description 6
- 239000000203 mixture Substances 0.000 description 5
- GHCZTIFQWKKGSB-UHFFFAOYSA-N 2-hydroxypropane-1,2,3-tricarboxylic acid;phosphoric acid Chemical compound OP(O)(O)=O.OC(=O)CC(O)(C(O)=O)CC(O)=O GHCZTIFQWKKGSB-UHFFFAOYSA-N 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 4
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 4
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 4
- 230000000844 anti-bacterial effect Effects 0.000 description 4
- 239000007864 aqueous solution Substances 0.000 description 4
- 239000000706 filtrate Substances 0.000 description 4
- 238000004816 paper chromatography Methods 0.000 description 4
- 239000008363 phosphate buffer Substances 0.000 description 4
- 238000006722 reduction reaction Methods 0.000 description 4
- VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 description 3
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 3
- 238000012009 microbiological test Methods 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- RMVMLZHPWMTQGK-SOUFLCLCSA-N (4s,4as,5as,6s,12ar)-4-(dimethylamino)-1,6,10,11,12a-pentahydroxy-3,12-dioxo-4a,5,5a,6-tetrahydro-4h-tetracene-2-carboxamide Chemical compound C1([C@H]2O)=CC=CC(O)=C1C(O)=C1[C@@H]2C[C@H]2[C@H](N(C)C)C(=O)C(C(N)=O)=C(O)[C@@]2(O)C1=O RMVMLZHPWMTQGK-SOUFLCLCSA-N 0.000 description 2
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 2
- 238000000862 absorption spectrum Methods 0.000 description 2
- 229960000583 acetic acid Drugs 0.000 description 2
- 229910021529 ammonia Inorganic materials 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 239000008366 buffered solution Substances 0.000 description 2
- 239000003638 chemical reducing agent Substances 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 238000004587 chromatography analysis Methods 0.000 description 2
- JCSGAUKCDAVARS-UHFFFAOYSA-N demethyltetracycline Natural products CN(C1C(=C(C(C2(C(=C3C(C4=C(C=CC=C4C(C3CC12)O)O)=O)O)O)=O)C(=O)N)O)C JCSGAUKCDAVARS-UHFFFAOYSA-N 0.000 description 2
- 230000008030 elimination Effects 0.000 description 2
- 238000003379 elimination reaction Methods 0.000 description 2
- 238000005755 formation reaction Methods 0.000 description 2
- 239000012362 glacial acetic acid Substances 0.000 description 2
- 229910052751 metal Inorganic materials 0.000 description 2
- 239000002184 metal Substances 0.000 description 2
- JLKDVMWYMMLWTI-UHFFFAOYSA-M potassium iodate Chemical compound [K+].[O-]I(=O)=O JLKDVMWYMMLWTI-UHFFFAOYSA-M 0.000 description 2
- 239000001230 potassium iodate Substances 0.000 description 2
- 229940093930 potassium iodate Drugs 0.000 description 2
- 235000006666 potassium iodate Nutrition 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- 239000007858 starting material Substances 0.000 description 2
- 239000000758 substrate Substances 0.000 description 2
- MTCQOMXDZUULRV-ADOAZJKMSA-N (4s,4as,5ar,12ar)-4-(dimethylamino)-1,10,11,12a-tetrahydroxy-3,12-dioxo-4a,5,5a,6-tetrahydro-4h-tetracene-2-carboxamide Chemical compound C1C2=CC=CC(O)=C2C(O)=C2[C@@H]1C[C@H]1[C@H](N(C)C)C(=O)C(C(N)=O)=C(O)[C@@]1(O)C2=O MTCQOMXDZUULRV-ADOAZJKMSA-N 0.000 description 1
- GUXHBMASAHGULD-SEYHBJAFSA-N (4s,4as,5as,6s,12ar)-7-chloro-4-(dimethylamino)-1,6,10,11,12a-pentahydroxy-3,12-dioxo-4a,5,5a,6-tetrahydro-4h-tetracene-2-carboxamide Chemical compound C1([C@H]2O)=C(Cl)C=CC(O)=C1C(O)=C1[C@@H]2C[C@H]2[C@H](N(C)C)C(=O)C(C(N)=O)=C(O)[C@@]2(O)C1=O GUXHBMASAHGULD-SEYHBJAFSA-N 0.000 description 1
- QGZKDVFQNNGYKY-UHFFFAOYSA-O Ammonium Chemical compound [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 description 1
- 102000016736 Cyclin Human genes 0.000 description 1
- 108050006400 Cyclin Proteins 0.000 description 1
- FMTDIUIBLCQGJB-UHFFFAOYSA-N Demethylchlortetracyclin Natural products C1C2C(O)C3=C(Cl)C=CC(O)=C3C(=O)C2=C(O)C2(O)C1C(N(C)C)C(O)=C(C(N)=O)C2=O FMTDIUIBLCQGJB-UHFFFAOYSA-N 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 239000005909 Kieselgur Substances 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- 239000005708 Sodium hypochlorite Substances 0.000 description 1
- 241000191940 Staphylococcus Species 0.000 description 1
- 241000191967 Staphylococcus aureus Species 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 239000000908 ammonium hydroxide Substances 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- 239000006172 buffering agent Substances 0.000 description 1
- 239000002021 butanolic extract Substances 0.000 description 1
- XMEVHPAGJVLHIG-FMZCEJRJSA-N chembl454950 Chemical compound [Cl-].C1=CC=C2[C@](O)(C)[C@H]3C[C@H]4[C@H]([NH+](C)C)C(O)=C(C(N)=O)C(=O)[C@@]4(O)C(O)=C3C(=O)C2=C1O XMEVHPAGJVLHIG-FMZCEJRJSA-N 0.000 description 1
- JFBJUMZWZDHTIF-UHFFFAOYSA-N chloro chlorite Chemical compound ClOCl=O JFBJUMZWZDHTIF-UHFFFAOYSA-N 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 238000002425 crystallisation Methods 0.000 description 1
- 230000008025 crystallization Effects 0.000 description 1
- 125000002147 dimethylamino group Chemical group [H]C([H])([H])N(*)C([H])([H])[H] 0.000 description 1
- 239000012259 ether extract Substances 0.000 description 1
- 239000012467 final product Substances 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 235000013675 iodine Nutrition 0.000 description 1
- PANJMBIFGCKWBY-UHFFFAOYSA-N iron tricyanide Chemical compound N#C[Fe](C#N)C#N PANJMBIFGCKWBY-UHFFFAOYSA-N 0.000 description 1
- 239000004922 lacquer Substances 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 230000002906 microbiologic effect Effects 0.000 description 1
- 238000004810 partition chromatography Methods 0.000 description 1
- 239000003208 petroleum Substances 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- 235000007715 potassium iodide Nutrition 0.000 description 1
- USHAGKDGDHPEEY-UHFFFAOYSA-L potassium persulfate Chemical compound [K+].[K+].[O-]S(=O)(=O)OOS([O-])(=O)=O USHAGKDGDHPEEY-UHFFFAOYSA-L 0.000 description 1
- 230000035484 reaction time Effects 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- SUKJFIGYRHOWBL-UHFFFAOYSA-N sodium hypochlorite Chemical compound [Na+].Cl[O-] SUKJFIGYRHOWBL-UHFFFAOYSA-N 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 229960004989 tetracycline hydrochloride Drugs 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Landscapes
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Description
Uppfinnare: C E Holmlund °eh W W Andres Prioritet begiird trent den 5 mars 1958 (Amerilcas fOrenta stater) Foreliggande uppfinning Ryser ett nytt forfarande for framstallning av medel med antibiotisk verkan och tillhorandc tctracyklinserien. Inventor: C E Holmlund ° eh W W Andres Priority Begired Trained March 5, 1958 (United States of America) Present Invention A new process is emerging for the manufacture of antibiotic agents and the associated cyclinic series.
Det 'utmarkande for ,forfarandet ar att man pa i .och .for sig kant siitt oxiderar ett tetracyklinantibiotikum, som saknar en hydroxigropp i 12a-stallning, i och for infOring av en 12a-thydroxigrupp. 12a-deoxitetracykliner utgora ,riya formingar av tetracyldinserien. 12a-deoxitetracyklin .framstalles .genom kemisk reduktion av tetracyklin med metallisk zink i en yattenlosning av ammoniak. Den anvanda ammonlaken utgores Himpligen av en -%-ig Det bar visat sig vara nodvandigt ,att anyanda vattenhaltig ammoniak sasom losningsmedelsmedium, eftersom. .andra 16sningsmedel, sasorn svagt &lira medier, ontingen ieke medhjulpa till reduktionen av tetracyklin liii 12adeoxitetracyklin eller medfora bildning av andra ,och olagliga reduktionsprodukter. Reaktionen kan utf5ras Add en temperator unellan ungefar 10 och 50° C men utfores gen yid ungefar rumstemperatur, dvs. Indian ungefar 20 Doh 25° C. R,eaktionstiden at ieke olagligt kritisk och kan i allmanhet uppga till mellan ungefar 1 och ungefar 4 timmar. En koncentration :ay ungelar 4 % (vikt/volym) av .tetraeyklinantiblotikumet i den vattenhaltiga ammoniaken at tillfred,sstallande for reaktionen. Den anyanda zinken bot lampligen foreligga i finfordelad form, t. ex. sasom zinkstoft, och metallen bOr anvandas i en mangd av minst 2 viktdelar per viktdel tetracyklinantibiotikum. Det at i allmanh,et joke nOdvandigt •att anyanda en metallmangd Over ungetar 4 viktdelar. The distinguishing feature of the process is that a tetracycline antibiotic, which lacks a hydroxy group in the 12a position, is oxidized in and of itself to introduce a 12a-thydroxy group. 12α-deoxytetracyclines form the same formations of the tetracyldine series. 12α-deoxytetracycline is produced by chemical reduction of tetracycline with metallic zinc in a surface solution of ammonia. The ammonium lacquer used is Himpligen consisting of a -% - ig It was found necessary that any other aqueous ammonia as a solvent medium, since Other solvents, such as weak & lira media, either do not assist in the reduction of tetracycline liii 12adeoxytetracycline or involve the formation of other, and illegal reduction products. The reaction can be carried out Add a temperature between about 10 and 50 ° C but is carried out at about room temperature, i.e. Indian about 20 Doh 25 ° C. The reaction time is not illegally critical and can generally amount to between about 1 and about 4 hours. A concentration of 4% (w / v) of the tetracycline antibiotic in the aqueous ammonia satisfies, satisfying the reaction. The anyanda zinc bot is aptly available in finely divided form, e.g. such as zinc dust, and the metal should be used in an amount of at least 2 parts by weight per part by weight of tetracycline antibiotic. That in general, a joke necessary • that anyanda a metal amount Over kids 4 parts by weight.
B,etingels,erna 'for den ,enligt uppfinningen utforda oxidationsreaktionen ,aro forhallandevis kritlska i den bemarkelsen, att pH-vardet, koncentrationen lay ,oxidationsme,dlet och tem peraturen paverka bade utbytet av slutpro,dukten ,och. reaktionshastigheten. Det liar vi-sat sig, att hydroxylering av 12a-deoxitetracyklin kan utfOras yid ,ett pH-yarde mellan ungefar 2 .och 7 ,och lampligen yid 'ett pHvarde maim ungefar 4,2 och 4,4 for -optimala resultat. Man halter lampligen pH-vardet -vid den -Onskade nivan ,genoin anvandning ay ett lampligt buffertmedel, t. ex. citrat-fosfathuftert, aven mu ,det ieke ,ar kritiskt att anvanda 'just ,denna buffert, .eftersoin ,dess ,enda funk. tion ,fir att ine,dgiva en pH-reglering. The conditions for the oxidation reaction which according to the invention challenge are relatively critical in the sense that the pH value, the concentration lay, the oxidizing agent, the medium and the temperature affect both the yield of the final product, and. the reaction rate. It has been found that hydroxylation of 12α-deoxytetracycline can be carried out by a pH range between about 2 and 7, and suitably by a pH value of about 4.2 and 4.4 for optimal results. The pH value is suitably adjusted to the desired level, using a suitable buffering agent, e.g. citrate-phosphate-hued, even mu, it ieke, is critical to use 'just, this buffer, .eftersoin, its, only funk. tion, fir to ine, give a pH control.
Reaktionen kan uttoras yid en temperatur unellan ,un.gefar 0 loch un,gefar 500 C och utfOres dampligen -vid ung-efar ramstemperatur, dvs. mellan ungefir 25 och 30° C. The reaction can be carried out at a temperature unellan, un.gefar 0 loch un, gefar 500 C and is carried out steam-at ung-efar frame temperature, i.e. between about 25 and 30 ° C.
,Sasom .exempel pa lampli,ga oxidationsmedel, vilka kunna unvandas vid iutforande av den !beskrivna 12a-hydroxy1eringen, ma namna,s kaliumpermanganat, kalimndikromat, kaliumferricyanid, .natriumnitrit, kaliumnitrit, kallunajodid, j od och kaliumpersulfat. Natriumhyp,oklorit och kaliumjodat ha a.ven anyants men 'aro icke lampliga, ,eftersom teaktions,hastigheten dr mycket lagre och en relativt lan,g tidryind .erfordras for den Onskade hydroxyleringen. Uppfinningen ar ,ernellertid- icke begriansadovan angivna oxidations medel utan andra sadana medel kunna 5..ven artvandas, om sa onskas. Den mangd oxidationsmedels som lerfordras few den Onskade ihy,droxyleringen kan variera irwm ett fOrhalilandeyis brett ,odurade. Det liar i allmanhet -visat sig, att ,oxidationsmedlet kan yara narvarande i reaktionsblandningen i en m,angd av unvefar 1/8 till .unciefar 2 ganger den m,olara ,koncentrationen ay 12a-deoxitetracyklinen. Examples of lamps are oxidizing agents which can be used in carrying out the described 12α-hydroxylation, such as potassium permanganate, potassium dichromate, potassium ferricyanide, sodium nitrite, potassium nitrite, potassium iodide, iodine and potassium persulfate. Sodium hypo, chlorochlorite and potassium iodate also have anyants but are not suitable, since the action, the rate is much lower and a relatively long time required for the desired hydroxylation. The invention is, however, not the oxidizing agent specified above, but other such agents may also be used, if desired. The amount of oxidizing agent required in the desired hydroxylation can vary in a wide, undurated form. It has generally been found that the oxidizing agent can be present in the reaction mixture in an amount of about 1/8 to about 2 times the molar concentration of the 12α-deoxytetracycline.
Uppfinningen ,ar lake pa. nagot ,satt begransad till .ovan beskriyna hydroxylering ay 1.2ad,eoxitetracyklin ,utan‘kan;sasom angiyits Even tillampas pa. ,hydroxylering :ax andra 12a-deoxitetracykliner, I. ex. 7-klor-6-demetyltetra- 2— — eyklin, 6- deoxitetracyklin, 6-demetyltetracyklin oeh 6-demety1-6-deoxitetracyklin. Dessutom kan den beskrivna.hydroxyleringen med :gott resultat tillampas pa 12a-cleoxidedimetylaminotetracyklin, varvid dedimetylaminotetracyklin bildas. Utgangsforeningen, 12a-deoxidedimetylaminotetracyklin, kan framstallas _genom alt tetracyklin bringas i kontakt med metallisk zink I svagt surt medium, t. ex. i isattika, under minst 72 timmar. Denna reaktion resulterar i eliminering av hydroxylgruppen i 12a-stallning i tetracyklinkarnan 'och i eliminering :av ,dimetylaminogruppen i 4-stallning i tetracyklinkarnan. The invention, ar lake pa. something, was limited to .ovan describe hydroxylation ay 1.2ad, eoxitetracycline, without ‘kan; as angiyits Even applied to. , hydroxylation: ax other 12α-deoxytetracyclines, I. ex. 7-chloro-6-demethyltetra-2--cycline, 6-deoxytetracycline, 6-demethyltetracycline and 6-demethyl-6-deoxytetracycline. In addition, the described hydroxylation with good results can be applied to 12α-cleoxide dimethylaminotetracycline to form dedimethylaminotetracycline. The starting compound, 12α-deoxide dimethylaminotetracycline, can be prepared by contacting all tetracycline with metallic zinc in weakly acidic medium, e.g. in glacial acetic acid, for at least 72 hours. This reaction results in the elimination of the hydroxyl group in the 12α-position in the tetracycline nucleus and in the elimination of the dimethylamino group in the 4-position in the tetracycline nucleus.
Den resulterande foreningen Ran benamnas 12a-deoxidedimetylaminotetracyldin. Denna reaktion med anvandning av -klortetracyklin sasom utgangs-material och resulterande i 12adeoxidedimetylaminoklortetracyklin beskrives i J. A. C. S 76,p. 3574 (1954). The resulting compound Ran is named 12α-deoxide dimethylaminotetracyldin. This reaction using -chlorotetracycline as starting material and resulting in 12-oxide dimethylaminochlorotetracycline is described in J. A. C. S 76, p. 3574 (1954).
Uppfinningen askadliggifires narmare me-deist -foljande exempt, van i temp-eraturerna angivas i Celsiusgrader. The invention is further exemplified by the following methods, which are set forth in degrees Celsius.
Exempel 1. 2 g tetracyklinhydroklorid 15- sas i 50 ml vattenhaltig 15 %-ig 'ammoniumhydroxid. 4 g zinkstoft tillsattas :och blandningen oniroreis 2 timmar. Overskottet zink :avfiltreras och .filtratet behandlas med ,koncentrerad saltsyra, tills pH-vardet är 7. Raprodukten avfiltreras :och suspenderas 'any° i 500 ml vatten saint bringas I losning vid pH 1,5.- Losningen klarnas over diatomacejord. Man installer sedan filtratets pH-varde pa 4,0 till 4,5, avfiltrerar en ringa mangd fast enbstans och extraherar ,det 'Mara :filtratet onisorgsfullt med eter i en vatske-vatske-extraktor. Eterextraktet ger 750 mg kristallin 12adeoxitetraeyklin, som omkristalliseras ur N,Ndimetylformamid:och,metanol. Example 1. 2 g of tetracycline hydrochloride are added to 50 ml of aqueous 15% ammonium hydroxide. 4 g of zinc dust are added: and the mixture is stirred for 2 hours. The excess zinc is filtered off and the filtrate is treated with concentrated hydrochloric acid until the pH is 7. The rap product is filtered off and suspended in 500 ml of water and brought to a solution at pH 1.5. The solution is clarified over diatomaceous earth. The pH of the filtrate is then installed at 4.0 to 4.5, a small amount of solid is filtered off and the filtrate is carefully extracted with ether in a liquid-liquid extractor. The ether extract gives 750 mg of crystalline 12-deoxytetracycline, which is recrystallized from N, N-dimethylformamide and methanol.
Exempel 2. Till en kolv med en volym av 4 liter 'sattas 800 nil citrat-fosfathuffert (pH 4,4), 100 ml av en vattenlosning .av notriumnitrit i en koncentration ov 800 g/ml och 100 ml ov en surgjord losning av 12a-deoxitetraeyk1in (framstalld enligt exempel 1) i en koncentration av 10 mg/ml. Man onnor reaktionsblandningen pa en fram- och atergaende skakanordning under 3 timmar. Darefter installer man reaktionsblandningen pa pH 8,5 —8,6, extraherar flera ganger med butanol, koncentrerar de sammansla:gna butanolextrakten till ringa volym ,och utfaller den rita tetracyklinen genom tillsats ,av 10 volymdelar petroleumeter. Tetracyklinen befrias fran storsta delen av de ingaende :fororeningarna genom fordelningskromatografering :och :efterfoljande ,kristallisation. Den kristallina tetracyklinen identifieras genom bestamning :av infrarodabsorptionsspektrum, ultraviolettabsorptionsspektruln, papperskromatografering och genom bestamning av den mikrobiologiska aktiviteten. Example 2. To a 4 liter flask was added 800 ml of citrate-phosphate buffer (pH 4.4), 100 ml of an aqueous solution of sodium nitrite at a concentration of 800 g / ml and 100 ml of an acidified solution of 12α-deoxytetracycline (prepared according to Example 1) at a concentration of 10 mg / ml. The reaction mixture is stirred on a reciprocating shaker for 3 hours. The reaction mixture is then installed at pH 8.5 to 8.6, extracted several times with butanol, the combined butanol extracts are concentrated to a small volume, and the drawn tetracycline is precipitated by the addition of 10 parts by volume of petroleum ether. The tetracycline is freed from most of the constituents: the impurities by partition chromatography: and: subsequent crystallization. The crystalline tetracycline is identified by determination: of the infrared absorption spectrum, ultraviolet absorption spectrum, paper chromatography and by determination of the microbiological activity.
Exempel 3. 0,5 ml av en vattenliisning air 12a-deoxitetracyklin med en koncentration av mg/m1 (framstalld enligt exempel 1) sattas till 4 ml .av en eitrat-fosfathuffert, framstalld vid pH 4,4. 0,5 ml ay en losning av .kaliumpermanganat med koncentrationen 460 pg/aul tillsattes och blandningen omr8res 2 ,timmar vid en temperatur av 28°. Ett prom av blandningen analyseras ,och visar sig vara i huvudsak fritt Iran 12a-deoxitetracyklin. Reaktionsblandningen provas mot Staphylococcus aurens, varvid det visar sig alt reaktionsblandningen har typisk tetracyklinantibakteriell aktivitet. Example 3. 0.5 ml of an aqueous solution of air 12a-deoxytetracycline at a concentration of mg / ml (prepared according to Example 1) is added to 4 ml of an etherate-phosphate buffer prepared at pH 4.4. 0.5 ml of a solution of potassium permanganate at a concentration of 460 pg / ul was added and the mixture was stirred for 2 hours at a temperature of 28 °. A prom of the mixture is analyzed, and turns out to be essentially free Iran 12a deoxytetracycline. The reaction mixture is tested against Staphylococcus aurens, it being found that the reaction mixture typically has tetracycline antibacterial activity.
.Exempel 4. Man upprepar forsaket i exempel 3 men .anyander 0,5 ml av en losning av kaliumdikromat med -koneentrationen 860 pg/m1 sasom oxidationsmedel. Reaktionen utfares under 2 timmar mid 28°. Papperskromatagrafering visar narvaro air tetracyklin. Example 4. The experiment of Example 3 is repeated, but using 0.5 ml of a solution of potassium dichromate with a concentration of 860 pg / ml as oxidizing agent. The reaction is carried out for 2 hours at 28 °. Paper chromatography shows narvaro air tetracycline.
Exempel 5. Forsiiket i exempel 3 iupprepas men med anvandning av 0,5 ml av en losning av kaliumferrieyanid med koneentrationen 960 pg/ml sasom oxidationsmedel. Reaktionen utfOres under 2 timmar vid 28°. P:apperskromatografering visar narvaro ,av tetracyklin. Example 5. The procedure of Example 3 is repeated but using 0.5 ml of a solution of potassium ferric cyanide with a concentration of 960 pg / ml as oxidizing agent. The reaction is carried out for 2 hours at 28 °. P: Appear chromatography shows the presence of tetracycline.
Exempel 6. Farsoket i exempel 3 upprepas men med anvandning ay 0,5 ml ,av en losning ay ikallumpersulfat med koncentrationen 1580 ,ag/m1 ,sasom oxidationsmedel. Reaktionen utf Ores under 2 timmar vid 28°. Papperkromatografering visor narvaro air tetratyklin. Example 6. The hazard test in Example 3 is repeated, but using 0.5 ml of a solution of lumpersulfate with a concentration of 1580, ag / ml, as oxidizing agent. The reaction is carried out for 2 hours at 28 °. Paper chromatography visor narvaro air tetracycline.
Exempel 7. Fors:oket i exempel 3 upprepas men med anvandning av 0,5 nil ay en Riming av jod med :koncentrationen 480 ggind sasom oxidationsmedel. Reaktionen ,utfores vid 28° under 2 thmuar. Papperskromatografering visar narvaro .av tetracyklin. Example 7. The experiment of Example 3 is repeated but using 0.5 .mu.l of an iodine broth with a concentration of 480 ggind as oxidizing agent. The reaction is carried out at 28 ° for 2 hours. Paper chromatography shows the presence of tetracycline.
Exempel 8. Forsoket 1 exempel 3 ,upprepas men med .anvandning av 0,5 ml ay en losning am kaliumnitrit :med koncentrationen 1000: pg/m1 -sasom ,oxidationsmedel. Reaktionen utfares under 2 timmar yid 28°. P:app.erskromatografering visar narvaro ay tetracyklin. Example 8. The experiment of Example 3 is repeated, but using 0.5 ml of a solution of potassium nitrite: at the concentration of 1000: pg / ml, as oxidizing agent. The reaction is carried out for 2 hours at 28 °. P: App.er chromatography shows the presence of tetracycline.
Exempel 9. Forsoket i exempel 3 upprepas men med anvandning :av en ekvivatent ,mangd kaliumjodat sasom oxidationsmedel. Reaktionen utfOres sasom i foregaende exempel men langre lid erfordras innan reaktionsblandningen visar sig innehalla tetracyklin. Example 9. The experiment of Example 3 is repeated but using: of an equivalent amount of potassium iodate as oxidizing agent. The reaction is carried out as in the previous example, but a longer time is required before the reaction mixture is found to contain tetracycline.
Exempel 10. ForsOket i exempel 3 upprepas men med anvandning ay en ekvivalent mangd natriumhypoklorit sasom oxidationsmedel. Reaktionen utfores sasom i fore:gaende exempel men erfordrar langre lid, innan reaktionsblandningen visar narvaro ay tetracyklin. Example 10. The experiment of Example 3 is repeated but using an equivalent amount of sodium hypochlorite as the oxidizing agent. The reaction is carried out as in the foregoing example but requires longer suffering before the reaction mixture shows the presence of tetracycline.
Exempel 11. 2,5 ml av en metanolltisning av 12a-deoxidedimetylaminotetracyklin med en koncentration ay 1 mg/ml, som :framstallts genom ,omsattning av tetracyklin aired metallisk zink i isattika under 72 timmar, sat-Ms till 1 ml citrat-fosfatbuffert, framstalid vid pH 4,4. 1,5 ml ay en vattenlosning av natriumnitrit med koncentrationen 1300 pg/m1 till- — —3 sattas oak blandningen .oinrores 2 timmar vid 28°. En 12a-hydroxylering av .s.ubstratet sker sasom visas av den Rade bakteriella aktiviteten vid turbidimetrisk provning av portioner av reaktionsblandningen mot Mikrococcus pyogenes. Example 11. 2.5 ml of a methanol thaw of 12α-deoxide dimethylaminotetracycline at a concentration of 1 mg / ml, as: prepared by reacting tetracycline aired metallic zinc in glacial acetic acid for 72 hours, sat-Ms to 1 ml of citrate-phosphate buffer, prepared at pH 4.4. 1.5 ml of an aqueous solution of sodium nitrite at a concentration of 1300 pg / ml are added to the mixture. The mixture is stirred for 2 hours at 28 °. A 12α-hydroxylation of the substrate occurs as evidenced by the Rade bacterial activity in turbidimetric testing of portions of the reaction mixture against Micrococcus pyogenes.
Turbidimetrisk prov- Tid i timmaraing vg/m1 sasom dull- metylaminotetracyklin 0 2108 Exempel 12. 7-klor-6-demetyl-12a-deoxitetracyklin framstalles genom .kemisk reduktion av tetracyklin med inetallisk zink i en vattenlosning av ammoniak. Efter fullbordad reaklion avfiltrerar man overskottet zink och avkyler filtratet i ett isbad samt surglir med koncentrerad saltsyra. Reaktionsblandningen utspades med eitrat-foslatbuffert (pH 4,4), varefter en spektrofotometrisk provning av losningen visar narvaro av ungefar 850 ytml av 12a-deoxiprodukten. Till en kolv med en volym av 50 nil sattes 1 nil av derma till pH 4,4 buffrade substratlosning och 1 ml av en losning, som innehaller 52 yArni natriumnitrit. Kolven skakas sedan pa en fram- och aterghende skakanordning under 2 tinamar vid 28°. Vid denna tidpunkt visar en spektrofotometrisk provning en sankning av koncentrationen av 7-klor-6-demety1-12a-deolitetracyklin fran en ursprungllg koncentration av 430 pg/ml till 45 ,ug/ml. En .mikrobiologisk provning visar en Riling av den antibakteriella aktiviteten uttryckt sasom 7-klor-6-demetyltetracyklin, fran ett ursprungligt varde aN pg/m1 till mer an 100 pg/ml. Turbidimetric test time per hour vg / ml as dull methylaminotetracycline 2108 Example 12. 7-Chloro-6-demethyl-12α-deoxytetracycline is prepared by chemical reduction of tetracycline with metallic zinc in an aqueous solution of ammonia. After completion of the reaction, the excess zinc is filtered off and the filtrate is cooled in an ice bath and acidified with concentrated hydrochloric acid. The reaction mixture was diluted with citrate-phosphate buffer (pH 4.4), after which a spectrophotometric test of the solution showed the presence of about 850 ml of the 12α-deoxy product. To a 50 nil volume flask was added 1 nil of this to pH 4.4 buffered substrate solution and 1 ml of a solution containing 52 .mu.l of sodium nitrite. The flask is then shaken on a reciprocating shaker for 2 minutes at 28 °. At this time, a spectrophotometric test shows a decrease in the concentration of 7-chloro-6-demethyl-12α-deolithetracycline from an initial concentration of 430 pg / ml to 45 .mu.g / ml. A microbiological test shows a trace of the antibacterial activity expressed as 7-chloro-6-demethyltetracycline, from an initial value of pN / ml to more than 100 pg / ml.
Exempel 13. Forsoket i foreglende exempel upprepas men med anviindnin.g av 6-demety1-12a-deoxitetracyklin sasom 12a-deoxitetracyklin. Koncentrationen i citrat-fosfatbuffrad losning lar .ungefar 1100 pg/ml. Den anvanda natriumnitritlosningen ;har en koncentration av 70 pg/ml. Efter 2 Hinman reaktion visar en spektrofotometrisk provning en sankning av koncentrationen .av 6-demetyl12a-deoxitetracyklin frail ett ursprungligt van-de av 550 pg/m1 till 72 pg/ml. En mikrobiologisk provning visar en okning av den antibakteriella aktiviteten, uttryckt ,sasom 6-demetyltetracyklin, frAn ett ursprungligt varde av 18 pg/ml till 152 pg/ml. Example 13. The experiment of the preceding example is repeated but using 6-demethyl-12α-deoxytetracycline such as 12α-deoxytetracycline. The concentration in citrate-phosphate buffered solution is approximately 1100 pg / ml. The sodium nitrite solution used has a concentration of 70 pg / ml. After 2 Hinman reaction, a spectrophotometric test shows a decrease in the concentration of 6-demethyl12a-deoxytetracycline from an initial level of 550 pg / ml to 72 pg / ml. A microbiological test shows an increase in antibacterial activity, expressed as 6-demethyltetracycline, from an initial value of 18 pg / ml to 152 pg / ml.
Exempel 14. Forsake i exempel 12 upprepas men aped anvandning av 6,12a-dideoxitetra cyklin. Koncentrationen .darav i citrai4osfatbuffrad lOsning uppgar till ungeflir 650 pg/ml. Den anvanda natriumnitritlosningen ihar en koncentration av 70 pg/ml. Biter avslutad reaktion visar en .spektrofotometrisk provning en sankning av koncentrationen av 6,12a-dideoxitetracyklin fran ett ,ursprungligt varde av 3lag/nd till 78 pg/ml. En mikrobiologisk provning visar en Ruing ,av den antibakteriella aktiviteten, uttryckt sasom 6-deoxitetracyklin, fran ett ursprungligt varde av 28 pg/m1 till 92 pg/ml. Example 14. The experiment of Example 12 is repeated but aped using 6,12a-dideoxytetra cyclin. The concentration of this in citric phosphate buffered solution is approximately 650 pg / ml. The sodium nitrite solution used has a concentration of 70 pg / ml. Bit completed reaction shows a spectrophotometric test showing a decrease in the concentration of 6,12a-dideoxytetracycline from an initial value of 3 layers / nd to 78 pg / ml. A microbiological test shows a Ruing, of the antibacterial activity, expressed as 6-deoxytetracycline, from an initial value of 28 pg / ml to 92 pg / ml.
Claims (5)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE174792T |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SE174792C1 true SE174792C1 (en) | 1961-01-01 |
Family
ID=41964059
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SE174792D SE174792C1 (en) |
Country Status (1)
| Country | Link |
|---|---|
| SE (1) | SE174792C1 (en) |
-
0
- SE SE174792D patent/SE174792C1/sv unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Kumar et al. | Indium mediated allylation of C N compounds in aqueous media | |
| Cartledge et al. | Oxalato complex compounds of tervalent manganese | |
| DE2219454A1 (en) | Cephalosporin derivatives | |
| CA1081218A (en) | Rifamycin compounds | |
| Heacock et al. | The Chemistry of the" aminochromes": Part I. The Preparation and Paper Chromatography of Pure Adrenochrome | |
| SE174792C1 (en) | ||
| US2890225A (en) | Process for the conversion of dihydroquercetin to quercetin | |
| UA41902C2 (en) | process for producing asitromycin dihydrochloride | |
| CH493449A (en) | Selective oxidation in presence of 11-hydroxy groups in | |
| GB1008850A (en) | Chemical compounds and process of preparing same | |
| EP0112629B1 (en) | Plant growth regulators | |
| DE2303022C2 (en) | Process for the preparation of 3-carbamoyloxymethylcephalosporins | |
| US2787578A (en) | Recovery and purification of vitamin b12 | |
| Pocker et al. | Reversible hydration of pteridine. General acid-base catalysis, solvent deuterium isotope effects, and transition state characterization | |
| US2631964A (en) | Recovery of vitamin b12 | |
| NL151436B (en) | PROCESS FOR PREPARING AN ANTIBIOTIC BY A STREPTOMYCETE, OF THE SPECIES STREPTOMYCES RIMOSUS. | |
| Hildrum et al. | Factors influencing the rate of formation of volatile N-nitrosamines during the nitrosation of spermidine | |
| US3180861A (en) | Method of producing acyl derivatives of penicillin | |
| Derieg et al. | 3-Aminoquinazolines: Structural assignments | |
| de Armas et al. | Stereoselective Radical CC Bond Forming using Suarez'Protocol: A Non Reductive Process. | |
| DE60006093T2 (en) | METHOD FOR PRODUCING PHENYL GLYOXYL ESTER OXIME | |
| Chihara et al. | SELECTIVE PROTECTION OF CARBONYL COMPOUNDS BY GIRARD’S REAGENT USING SILICA GEL AS A SOLID SUPPORT | |
| Harris et al. | Studies in the biological fixation of nitrogen: XII. The acetylation of hydrazine by Azotobacter vinelandii | |
| Bacon et al. | 386. 3: 4-Dimethyl galactose | |
| JPH0567617B2 (en) |